Skip to content
healthcare.dev

Sodium Phosphates

NDC 63323-170, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, injection, solution, from Fresenius Kabi USA, LLC.

Product NDC
63323-170
Status
Listed
Labeler
Fresenius Kabi USA, LLC
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
UNAPPROVED DRUG OTHER
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63323-170 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE276 mg/mL
  • SODIUM PHOSPHATE, DIBASIC, ANHYDROUS142 mg/mL
Package NDCNDC-11Package
63323-170-056332301700525 VIAL, SINGLE-DOSE in 1 TRAY (63323-170-05) / 5 mL in 1 VIAL, SINGLE-DOSE
63323-170-156332301701525 VIAL, SINGLE-DOSE in 1 TRAY (63323-170-15) / 15 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

Use it

Look up 63323-170 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63323-170 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63323-170. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.